Zheng Chen, OD
Optometry · Stanford
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 9
- 4 carriers
- Office
- 1
On the public record
- 1 Medical Board action on record
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chen’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
9 of 9 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C33830 · Cancelled
Licence status: Cancelled · since 1971 · University of Kentucky College of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
Public record actions
| 2008-09-18 | Board disciplineDiscipline | Revoked. · 17 2007185213 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$28,730
Medicare paid this office $28,730 for 232 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (30+ min) | 133 | $10,246 | $77 |
| Return visit (30+ min) | 54 | $5,905 | $105 |
| Short return visit (20+ min) | 53 | $5,176 | $77 |
| New patient visit (45+ min) | 16 | $2,526 | $158 |
| Imaging of optic nerve | 93 | $1,886 | $20 |
See all 7 services
| New patient visit (30+ min) | 133 | $10,246 | $77 |
| Return visit (30+ min) | 54 | $5,905 | $105 |
| Short return visit (20+ min) | 53 | $5,176 | $77 |
| New patient visit (45+ min) | 16 | $2,526 | $158 |
| Imaging of optic nerve | 93 | $1,886 | $20 |
| Imaging of retina | 59 | $1,552 | $25 |
| Exam of visual field with extended testing | 13 | $514 | $40 |
Who their Medicare patients are
232 Original Medicare patients in 2024. Average age 73 · Under 65 7% · 85 and older 11% · Women 52% · Also on Medicaid 32% · Health risk score 1.21. Above the middle of the specialty; the typical optometry clinician is at 0.97.
Conditions among them: High blood pressure 72% · Diabetes 29% · Coronary heart disease 22% · Chronic kidney disease 19% · Cancer 19% · Depression 16% · Heart failure 14% · COPD 14% · Atrial fibrillation 13% · Stroke 10%.
The office billed $164,606, Medicare allowed $43,875 and paid $28,730; for 462 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 232 | 462 | 73 | 1.21 | $164,606 | $28,730 |
| 2023 | 67 | 109 | 72 | 1.15 | $33,459 | $7,636 |
| 2022 | 71 | 103 | 73 | 1.14 | $11,411 | $5,398 |
| 2014 | 24 | 30 | 73 | 1.34 | $3,984 | $2,601 |
| 2013 | 32 | 47 | 73 | 0.94 | $5,989 | $3,574 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| New patient visit (30+ min) | 38 | $3,451 | $91 |
| Return visit (30+ min) | 19 | $1,991 | $105 |
| Imaging of optic nerve | 19 | $384 | $20 |
2022: 3 services
| New patient visit (30+ min) | 43 | $2,819 | $66 |
| Return visit (30+ min) | 17 | $1,242 | $73 |
| Imaging of optic nerve | 13 | $246 | $19 |
2014: 1 service
| Established patient complete exam of visual system | 14 | $1,164 | $83 |
2013: 2 services
| Established patient complete exam of visual system | 18 | $1,363 | $68 |
| New patient complete exam of visual system | 12 | $1,123 | $94 |
Medicaid work
$235 in 2024
Medicaid paid $235 for 37 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 12 | $178 |
| DETERMINATION REFRACTIVE STATE | 25 | $58 |
| 2024 | 37 | 2 | 13 | $235 |
| 2023 | 543 | 4 | 31 | $2,731 |
| 2022 | 226 | 4 | 22 | $1,148 |
| 2021 | 412 | 4 | 25 | $1,610 |
| 2020 | 380 | 4 | 27 | $2,101 |
| 2019 | 297 | 3 | 35 | $1,340 |
See the largest Medicaid services in earlier years
2023
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 158 | $1,335 |
| Frames, purchases | 141 | $633 |
| DETERMINATION REFRACTIVE STATE | 179 | $453 |
| Fitting of monofocal spectacles | 65 | $310 |
2022
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 80 | $639 |
| Frames, purchases | 29 | $270 |
| DETERMINATION REFRACTIVE STATE | 103 | $180 |
| Fitting of monofocal spectacles | 14 | $58 |
2021
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 92 | $710 |
| Frames, purchases | 92 | $388 |
| DETERMINATION REFRACTIVE STATE | 188 | $317 |
| Fitting of monofocal spectacles | 40 | $194 |
2020
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 105 | $1,207 |
| DETERMINATION REFRACTIVE STATE | 159 | $353 |
| Frames, purchases | 60 | $347 |
| Fitting of monofocal spectacles | 56 | $194 |
2019
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 55 | $604 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 57 | $391 |
| DETERMINATION REFRACTIVE STATE | 185 | $346 |
Drugs they prescribed that Part D paid
$28,753
Pharmacies billed $28,753 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 428) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
260 generic and 168 brand-name prescriptions · $28,753 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prednisolone Acetate | 113 | $5,147 | $46 |
| Moxifloxacin | 117 | $2,094 | $18 |
| Ketorolac Tromethamine | 69 | $1,561 | $23 |
| Latanoprost | 44 | $212 | $5 |
| Timolol Maleate | 13 | $116 | $9 |
Year by year
| 2024 | 428 | 126 | 0% (0) | 39% | $28,753 |
| 2023 | 192 | 55 | 0% (0) | 42% | $14,129 |
| 2022 | 77 | 22 | 0% (0) | 45% | $6,668 |
| 2021 | 49 | None | 0% (0) | 49% | $2,259 |
| 2020 | 18 | None | 0% (0) | None | $157 |
| 2019 | 13 | None | 0% (0) | 0% | $100 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Prednisolone Acetate | 38 | $2,122 | $56 |
| Moxifloxacin | 36 | $1,169 | $32 |
| Ketorolac Tromethamine | 34 | $1,119 | $33 |
| Timolol Maleate | 13 | $955 | $73 |
| Latanoprost | 37 | $506 | $14 |
2022: 2 drugs
| Latanoprost | 34 | $514 | $15 |
| Timolol Maleate | 16 | $155 | $10 |
2021: 2 drugs
| Latanoprost | 23 | $259 | $11 |
| Timolol Maleate | 19 | $179 | $9 |
Money from drug and device companies
$60 in 2025
| 2025 | 2 | 3 | None | $60 |
| 2024 | 2 | 3 | None | $73 |
| 2023 | 1 | 1 | None | $19 |
| 2022 | 1 | 4 | None | $66 |
| 2021 | 3 | 8 | None | $141 |
| 2020 | 2 | 4 | None | $83 |
| 2019 | 5 | 7 | None | $104 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Johnson & Johnson Vision Care | None | $44 | 2 payments
|
| Alcon Vision | Precision7 | $16 | 1 payment
|
See all 3 published payments
| Johnson & Johnson Vision Care | Meals · 2025-11-04 | None | $27 |
| Johnson & Johnson Vision Care | Meals · 2025-06-30 | None | $17 |
| Alcon Vision | Meals · 2025-06-23 | Precision7 | $16 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $73
| Alcon Vision | Total30 | $42 | 2 payments
|
| Johnson & Johnson Vision Care | None | $30 | 1 payment
|
2023: $19
| Alcon Vision | Dailies | $19 | 1 payment
|
2022: $66
| Johnson & Johnson Vision Care | Acuvue | $66 | 4 payments
|
2021: $141
| Johnson & Johnson Vision Care | Acuvue | $95 | 5 payments
|
| Alcon Vision | Precision 1 | $25 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Infuse | $21 | 1 payment
|
2020: $83
| Johnson & Johnson Vision Care | Acuvue | $54 | 2 payments
|
| Alcon Vision | Dailies | $29 | 2 payments
|
2019: $104
| Johnson & Johnson Vision Care | Acuvue | $30 | 2 payments
|
| Alcon Vision | Dailies | $25 | 2 payments
|
| CooperVision | Multiple Brands Contact Lens | $21 | 1 payment
|
| Visioneering Technologies | None | $17 | 1 payment
|
| Plexus Optix | Unity Biosync Contact Lens With Hydramist | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1033442306
- Licence
- CA 33830TCalifornia C33830: Cancelled
- Trained
- New England College of Optometry, 2009
- Group
- Stanford Health Care
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2009-09-17
- NPI last updated
- 2021-08-02
- NPI record certified
- 2021-08-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 479 University Ave, Palo Alto, CA, 94301 · 1630 Oakland Rd Ste A115, San Jose, CA, 95131